Advances in Neuroimaging for Neurodegenerative Disease Diagnosis

Recent breakthroughs in neuroimaging have transformed our ability to detect and track neurodegenerative diseases at their earliest stages. This session will focus on novel imaging techniques such as amyloid and tau PET scans, functional MRI (fMRI), diffusion tensor imaging (DTI), and molecular imaging that allow for precise visualization of pathological changes in the brain. Attendees will learn how these tools improve differential diagnosis, monitor disease progression, and assess treatment efficacy in clinical trials. This session is beneficial for radiologists, neurologists, and researchers working on neurodegeneration diagnostics.

    Related Conference of Advances in Neuroimaging for Neurodegenerative Disease Diagnosis

    June 22-23, 2026

    7th World Congress on Sleep Disorders and Therapeutics

    Amsterdam, Netherlands
    June 22-23, 2026

    18th Global Neurologists Meeting on Neurology and Neurosurgery

    Amsterdam, Netherlands
    June 22-23, 2026

    38th World Conference on Neurology

    Barcelona, Spain
    June 29-30, 2026

    37th Conference on Clinical Neuroscience and Neurogenetics

    Aix-en-Provence, France
    June 29-30, 2026

    39th European Neurology Congress

    London, UK
    July 20-21, 2026

    37th World Congress on Neurology and Neuroscience

    Amsterdam, Netherlands
    July 23-24, 2026

    14th International Conference on Cannabis & Medicinal Research

    Amsterdam, Netherlands
    September 18-19, 2026

    21st Annual Congress on Neuroscience

    Dubai, UAE
    November 16-17, 2026

    8th World Brain Congress

    Tokyo, Japan
    November 23-24, 2026

    16th Global Alzheimers Summit

    Paris, France
    December 21-22, 2026

    6th International Conference on Child Neurology

    Paris, France

    Advances in Neuroimaging for Neurodegenerative Disease Diagnosis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in